{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:38:31Z","timestamp":1792744711203,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04594-0","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:52:11Z","timestamp":1792741931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemokine receptor CXCR2 and plasminogen activator inhibitor-1 expression in colorectal adenocarcinoma are associated with prognostic features"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1109-0019","authenticated-orcid":false,"given":"Lynn","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9530-5243","authenticated-orcid":false,"given":"Eundong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5208-1197","authenticated-orcid":false,"given":"Paul J.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2970-3022","authenticated-orcid":false,"given":"Xulang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1644-1324","authenticated-orcid":false,"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-9772","authenticated-orcid":false,"given":"Noureldien","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7005-6278","authenticated-orcid":false,"given":"Hwajeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"4594_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193353","author":"JE Hwang","year":"2024","unstructured":"Hwang JE, Kim SS, Bang HJ, Kim HJ, Shim HJ, Bae WK, et al. Tumor Immune Microenvironment Biomarkers for Recurrence Prediction in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiotherapy. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16193353.","journal-title":"Cancers (Basel)."},{"issue":"12","key":"4594_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41568-025-00872-1","volume":"25","author":"KB Kennel","year":"2025","unstructured":"Kennel KB, Greten FR. The immune microenvironment of colorectal cancer. Nat Rev Cancer. 2025;25(12):945\u201364. https:\/\/doi.org\/10.1038\/s41568-025-00872-1.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"4594_CR3","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reynies A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350\u20136. https:\/\/doi.org\/10.1038\/nm.3967.","journal-title":"Nat Med"},{"issue":"2","key":"4594_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00428-024-03746-3","volume":"484","author":"PD Dunne","year":"2024","unstructured":"Dunne PD, Arends MJ. Molecular pathological classification of colorectal cancer-an update. Virchows Arch. 2024;484(2):273\u201385. https:\/\/doi.org\/10.1007\/s00428-024-03746-3.","journal-title":"Virchows Arch"},{"issue":"3","key":"4594_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4594_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.4682","volume":"8","author":"A Bussetty","year":"2025","unstructured":"Bussetty A, Shen J, Benias PC, Ma M, Stewart M, Trindade AJ. Incidence of pancreas and colorectal adenocarcinoma in the US. JAMA Netw Open. 2025;8(4):e254682. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.4682.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4594_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molmed.2023.09.003","volume":"30","author":"G Lazennec","year":"2024","unstructured":"Lazennec G, Rajarathnam K, Richmond A. CXCR2 chemokine receptor - a master regulator in cancer and physiology. Trends Mol Med. 2024;30(1):37\u201355. https:\/\/doi.org\/10.1016\/j.molmed.2023.09.003.","journal-title":"Trends Mol Med"},{"key":"4594_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042168","author":"J Korbecki","year":"2022","unstructured":"Korbecki J, Kupnicka P, Chlubek M, Goracy J, Gutowska I, Baranowska-Bosiacka I. CXCR2 receptor: regulation of expression, signal transduction, and involvement in cancer. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23042168.","journal-title":"Int J Mol Sci"},{"key":"4594_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102328","author":"F Boissiere-Michot","year":"2021","unstructured":"Boissiere-Michot F, Jacot W, Massol O, Mollevi C, Lazennec G. CXCR2 levels correlate with immune infiltration and a better prognosis of triple-negative breast cancers. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13102328.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4594_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01355-1","volume":"20","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Mo F, Li Q, Han X, Shi H, Chen S, et al. Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin. Mol Cancer. 2021;20(1):62. https:\/\/doi.org\/10.1186\/s12943-021-01355-1.","journal-title":"Mol Cancer"},{"issue":"1","key":"4594_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/PAS.0b013e31817ec2b1","volume":"33","author":"JK Greenson","year":"2009","unstructured":"Greenson JK, Huang SC, Herron C, Moreno V, Bonner JD, Tomsho LP, et al. Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol. 2009;33(1):126\u201333. https:\/\/doi.org\/10.1097\/PAS.0b013e31817ec2b1.","journal-title":"Am J Surg Pathol"},{"issue":"17","key":"4594_CR12","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1016\/j.ejca.2005.07.017","volume":"41","author":"K Klintrup","year":"2005","unstructured":"Klintrup K, Makinen JM, Kauppila S, Vare PO, Melkko J, Tuominen H, et al. Inflammation and prognosis in colorectal cancer. Eur J Cancer. 2005;41(17):2645\u201354. https:\/\/doi.org\/10.1016\/j.ejca.2005.07.017.","journal-title":"Eur J Cancer"},{"issue":"17","key":"4594_CR13","doi-asserted-by":"publisher","first-page":"28442","DOI":"10.18632\/oncotarget.16086","volume":"8","author":"J Zhao","year":"2017","unstructured":"Zhao J, Ou B, Feng H, Wang P, Yin S, Zhu C, et al. Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer. Oncotarget. 2017;8(17):28442\u201354. https:\/\/doi.org\/10.18632\/oncotarget.16086.","journal-title":"Oncotarget"},{"issue":"4","key":"4594_CR14","first-page":"5883","volume":"8","author":"W Wu","year":"2015","unstructured":"Wu W, Sun C, Xu D, Zhang X, Shen W, Lv Y, et al. Expression of CXCR2 and its clinical significance in human colorectal cancer. Int J Clin Exp Med. 2015;8(4):5883\u20139.","journal-title":"Int J Clin Exp Med"},{"key":"4594_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.biopha.2018.05.119","volume":"105","author":"S Li","year":"2018","unstructured":"Li S, Wei X, He J, Tian X, Yuan S, Sun L. Plasminogen activator inhibitor-1 in cancer research. Biomed Pharmacother. 2018;105:83\u201394. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.119.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"4594_CR16","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/cam4.651","volume":"5","author":"M Hirahata","year":"2016","unstructured":"Hirahata M, Osaki M, Kanda Y, Sugimoto Y, Yoshioka Y, Kosaka N, et al. PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma. Cancer Med. 2016;5(5):892\u2013902. https:\/\/doi.org\/10.1002\/cam4.651.","journal-title":"Cancer Med"},{"issue":"2","key":"4594_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3892\/or.2016.5292","volume":"37","author":"X Wang","year":"2017","unstructured":"Wang X, Liu C, Wang J, Fan Y, Wang Z, Wang Y. Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-beta1\/Smad signaling pathway. Oncol Rep. 2017;37(2):747\u201353. https:\/\/doi.org\/10.3892\/or.2016.5292.","journal-title":"Oncol Rep"},{"key":"4594_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cells13100796","author":"RP Czekay","year":"2024","unstructured":"Czekay RP, Higgins CE, Aydin HB, Samarakoon R, Subasi NB, Higgins SP, et al. SERPINE1: role in cholangiocarcinoma progression and a therapeutic target in the desmoplastic microenvironment. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13100796.","journal-title":"Cells"},{"issue":"1","key":"4594_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-025-10050-6","volume":"41","author":"Z Yang","year":"2025","unstructured":"Yang Z, Zhong D, Hu X, Chen W, Liao Y, He X. NFATC2\/SERPINE1\/JAK3\/STAT3 signaling feedback loop in gastric cancer: immune evasion and anti-PD-1 resistance. Cell Biol Toxicol. 2025;41(1):102. https:\/\/doi.org\/10.1007\/s10565-025-10050-6.","journal-title":"Cell Biol Toxicol"},{"key":"4594_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6504960","author":"B Markl","year":"2017","unstructured":"Markl B, Hardt J, Franz S, Schaller T, Schenkirsch G, Kriening B, et al. Tumor budding, uPA, and PAI-1 in colorectal cancer: update of a prospective study. Gastroenterol Res Pract. 2017. https:\/\/doi.org\/10.1155\/2017\/6504960.","journal-title":"Gastroenterol Res Pract"},{"issue":"6","key":"4594_CR21","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.surg.2015.04.053","volume":"158","author":"H Chen","year":"2015","unstructured":"Chen H, Peng H, Liu W, Sun Y, Su N, Tang W, et al. Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis. Surgery. 2015;158(6):1704\u201313. https:\/\/doi.org\/10.1016\/j.surg.2015.04.053.","journal-title":"Surgery"},{"issue":"7","key":"4594_CR22","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002652RR","volume":"35","author":"CC Gifford","year":"2021","unstructured":"Gifford CC, Lian F, Tang J, Costello A, Goldschmeding R, Samarakoon R, et al. PAI-1 induction during kidney injury promotes fibrotic epithelial dysfunction via deregulation of klotho, p53, and TGF-beta1-receptor signaling. FASEB J. 2021;35(7):e21725. https:\/\/doi.org\/10.1096\/fj.202002652RR.","journal-title":"FASEB J"},{"issue":"3","key":"4594_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/cas.12603","volume":"106","author":"T Desurmont","year":"2015","unstructured":"Desurmont T, Skrypek N, Duhamel A, Jonckheere N, Millet G, Leteurtre E, et al. Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival. Cancer Sci. 2015;106(3):262\u20139. https:\/\/doi.org\/10.1111\/cas.12603.","journal-title":"Cancer Sci"},{"key":"4594_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.canlet.2022.01.004","volume":"529","author":"H Wang","year":"2022","unstructured":"Wang H, Shao Q, Wang J, Zhao L, Wang L, Cheng Z, et al. Decreased CXCR2 expression on circulating monocytes of colorectal cancer impairs recruitment and induces re-education of tumor-associated macrophages. Cancer Lett. 2022;529:112\u201325. https:\/\/doi.org\/10.1016\/j.canlet.2022.01.004.","journal-title":"Cancer Lett"},{"key":"4594_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051071","author":"S Munoz-Galvan","year":"2020","unstructured":"Munoz-Galvan S, Rivero M, Peinado-Serrano J, Martinez-Perez J, Fernandez-Fernandez MC, Ortiz MJ, et al. PAI1 is a marker of bad prognosis in rectal cancer but predicts a better response to treatment with PIM inhibitor AZD1208. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9051071.","journal-title":"Cells"},{"issue":"30","key":"4594_CR26","doi-asserted-by":"publisher","first-page":"29016","DOI":"10.18632\/oncotarget.5032","volume":"6","author":"MA Pavon","year":"2015","unstructured":"Pavon MA, Arroyo-Solera I, Tellez-Gabriel M, Leon X, Viros D, Lopez M, et al. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients. Oncotarget. 2015;6(30):29016\u201333. https:\/\/doi.org\/10.18632\/oncotarget.5032.","journal-title":"Oncotarget"},{"issue":"2","key":"4594_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1309\/F32X-WQ20-T568-H8VP","volume":"122","author":"M Illemann","year":"2004","unstructured":"Illemann M, Hansen U, Nielsen HJ, Andreasen PA, Hoyer-Hansen G, Lund LR, et al. Leading-edge myofibroblasts in human colon cancer express plasminogen activator inhibitor-1. Am J Clin Pathol. 2004;122(2):256\u201365. https:\/\/doi.org\/10.1309\/F32X-WQ20-T568-H8VP.","journal-title":"Am J Clin Pathol"},{"issue":"6599","key":"4594_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/383441a0","volume":"383","author":"S Stefansson","year":"1996","unstructured":"Stefansson S, Lawrence DA. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature. 1996;383(6599):441\u20133. https:\/\/doi.org\/10.1038\/383441a0.","journal-title":"Nature"},{"issue":"6","key":"4594_CR29","doi-asserted-by":"publisher","first-page":"L496","DOI":"10.1152\/ajplung.00290.2015","volume":"310","author":"N Tiwari","year":"2016","unstructured":"Tiwari N, Marudamuthu AS, Tsukasaki Y, Ikebe M, Fu J, Shetty S. P53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure. Am J Physiol Lung Cell Mol Physiol. 2016;310(6):L496-506. https:\/\/doi.org\/10.1152\/ajplung.00290.2015.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"4594_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cyto.2007.10.006","volume":"41","author":"M Cheng","year":"2008","unstructured":"Cheng M, Li Y, Wu J, Nie Y, Li L, Liu X, et al. IL-8 induces imbalances between nitric oxide and endothelin-1, and also between plasminogen activator inhibitor-1 and tissue-type plasminogen activator in cultured endothelial cells. Cytokine. 2008;41(1):9\u201315. https:\/\/doi.org\/10.1016\/j.cyto.2007.10.006.","journal-title":"Cytokine"},{"issue":"3","key":"4594_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000085964","volume":"37","author":"H Terada","year":"2005","unstructured":"Terada H, Urano T, Konno H. Association of interleukin-8 and plasminogen activator system in the progression of colorectal cancer. Eur Surg Res. 2005;37(3):166\u201372. https:\/\/doi.org\/10.1159\/000085964.","journal-title":"Eur Surg Res"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04594-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:52:12Z","timestamp":1792741932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04594-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":31,"alternative-id":["4594"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04594-0","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"8 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board at Albany Medical College.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors (LG, EP, PJH, XZ, JZ, ND, HL) have no disclosures related to the content of the manuscript to report.","order":3,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}